default author photo

Drew Weissman

University of Pennsylvania - Department of Microbiology

SCHOLARLY PAPERS

4

DOWNLOADS

265

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Non-Inferiority Phase 2 Immunogenicity and Safety Study of 'Comvigen': A Model for Mrna Vaccine Development in Low- and Middle-Income Countries (LMICs)

Number of pages: 42 Posted: 28 Feb 2025
Chulalongkorn University - Thai Red Cross Emerging Infectious Diseases Clinical Centre, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, Thai Red Cross AIDS Research Centre, Bangkok, Chulalongkorn University, Chulalongkorn University, Chulalongkorn University, Armed Forces Research Institute of Medical Sciences, Mahidol University, Chulalongkorn University, National Center for Genetic Engineering and Biotechnology, Chulalongkorn University, Chulalongkorn University, Mahidol University, University of Pennsylvania - Department of Microbiology, University of Pennsylvania, Genevant Sciences Corporation, Genevant Sciences GmbH, BioNet-Asia Co Ltd, Chulalongkorn University and Independent
Downloads 119 (600,462)

Abstract:

Loading...

COVID-19 vaccine booster, Immunogenicity, Safety, Omicron, mRNA vaccine, Pandemic preparedness, Vaccine equity, Neutralizing antibody, T-cells

2.

Molecular Design Principles to Target mRNA Delivery With One-Component Ionizable Amphiphilic Janus Dendrimers Derived From Plant Phenolic Acids

Number of pages: 157 Posted: 09 Dec 2022
University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Roy & Diana Vagelos Laboratories, University of Pennsylvania - Department of Microbiology and University of Pennsylvania - Roy & Diana Vagelos Laboratories
Downloads 71 (867,774)

Abstract:

Loading...

Target mRNA Delivery, One-Component Vector, Ionizable Janus Dendrimer, Dendrimersome Nanoparticles, Molecular Design Principles, Vaccines, Nanotherapeutics, Plant Phenolic Acids, Simplified Preparation, Handling, Reduced Vaccine Price

3.

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

Number of pages: 59 Posted: 18 Feb 2022
Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, University of Pennsylvania - Department of Microbiology, Corporate Research Materials Lab, 3M Company, Infectious Disease Research Institute, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, BIOQUAL, BIOQUAL, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Government of the United States of America - Vaccine Research Center, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
Downloads 39 (1,196,171)

Abstract:

Loading...

4.

Vaccine Induction of CD4-Mimicking Broadly Neutralizing Antibody Precursors in Macaques

Number of pages: 67 Posted: 12 Apr 2023
Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Acuitas LLC, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Acuitas LLC, BIOQUAL, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
Downloads 36 (1,236,159)

Abstract:

Loading...

HIV vaccine, broadly neutralizing antibodies, rhesus macaques, CD4 binding site